Melanoma

• SWOG 0008, "Phase III Trial of High Dose Interferon Alfa-2b versus Cisplatin, Vinblastine, DTIC plus IL-2 and Interferon in Patients with High-Risk Melanoma."
  • Newly diagnosed disease or recurrent after lymphadenectomy
  • No prior chemo/radiation
  • No distant, ocular, mucosal or other melanoma of non-cutaneous origin.
  • We have no patients enrolled in this study.

« back to Clinical Trials list